ATE247956T1 - Verwendung von modafinil zur herstellung eines arzneimittels zur behandlung von vigilanzstörungen im zusammenhang mit myopathien - Google Patents
Verwendung von modafinil zur herstellung eines arzneimittels zur behandlung von vigilanzstörungen im zusammenhang mit myopathienInfo
- Publication number
- ATE247956T1 ATE247956T1 AT01903990T AT01903990T ATE247956T1 AT E247956 T1 ATE247956 T1 AT E247956T1 AT 01903990 T AT01903990 T AT 01903990T AT 01903990 T AT01903990 T AT 01903990T AT E247956 T1 ATE247956 T1 AT E247956T1
- Authority
- AT
- Austria
- Prior art keywords
- modafinil
- myopathies
- vigilancy
- treatment
- production
- Prior art date
Links
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 title abstract 2
- 208000021642 Muscular disease Diseases 0.000 title abstract 2
- 201000009623 Myopathy Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229960001165 modafinil Drugs 0.000 title abstract 2
- 229940126601 medicinal product Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0001211A FR2804322B1 (fr) | 2000-01-31 | 2000-01-31 | Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies |
| PCT/FR2001/000271 WO2001054648A2 (fr) | 2000-01-31 | 2001-01-29 | Traitement des troubles de la vigilance associes aux myopathies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE247956T1 true ATE247956T1 (de) | 2003-09-15 |
Family
ID=8846505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01903990T ATE247956T1 (de) | 2000-01-31 | 2001-01-29 | Verwendung von modafinil zur herstellung eines arzneimittels zur behandlung von vigilanzstörungen im zusammenhang mit myopathien |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6462089B1 (de) |
| EP (1) | EP1251842B1 (de) |
| JP (2) | JP2003521487A (de) |
| AT (1) | ATE247956T1 (de) |
| AU (1) | AU2001231931A1 (de) |
| DE (1) | DE60100660T2 (de) |
| DK (1) | DK1251842T3 (de) |
| ES (1) | ES2206400T3 (de) |
| FR (1) | FR2804322B1 (de) |
| MX (1) | MXPA02007236A (de) |
| PT (1) | PT1251842E (de) |
| TR (1) | TR200300575T3 (de) |
| WO (1) | WO2001054648A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005077894A1 (en) * | 2004-02-06 | 2005-08-25 | Cephalon, Inc. | Modafinil compositions |
| ES2277937T3 (es) * | 2000-07-27 | 2007-08-01 | Teva Pharmaceutical Industries Ltd. | Modafinilo puro y cristalino y su procedimiento de preparacion. |
| US20040048931A1 (en) | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
| US6992219B2 (en) * | 2002-08-09 | 2006-01-31 | Cephalon France | Modafinil polymorphic forms |
| US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
| US20040253308A1 (en) * | 2003-04-29 | 2004-12-16 | Barr Laboratories, Inc. | Surface-treated modafinil particles |
| CN100343228C (zh) * | 2006-02-17 | 2007-10-17 | 中国科学院上海有机化学研究所 | 高对映体选择性制备 2－二苯甲基亚磺酰基－乙酰胺单一对映体的方法 |
| WO2008003093A2 (en) * | 2006-06-29 | 2008-01-03 | Questcor Pharmaceuticals, Inc. | Pharmaceutical compositions and related methods of treatment |
| US20080181966A1 (en) * | 2006-10-18 | 2008-07-31 | Cephalon, Inc. | Modafinil pharmaceutical compositions |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1584462A (en) * | 1977-03-31 | 1981-02-11 | Lafon Labor | N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them |
| FR2593809B1 (fr) * | 1986-01-31 | 1988-07-22 | Lafon Labor | Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique |
| US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
| FR2771004B1 (fr) * | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
| US6346548B1 (en) * | 1999-08-16 | 2002-02-12 | Cephalon, Inc. | Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue |
-
2000
- 2000-01-31 FR FR0001211A patent/FR2804322B1/fr not_active Expired - Fee Related
- 2000-06-29 US US09/606,238 patent/US6462089B1/en not_active Expired - Lifetime
-
2001
- 2001-01-29 MX MXPA02007236A patent/MXPA02007236A/es active IP Right Grant
- 2001-01-29 ES ES01903990T patent/ES2206400T3/es not_active Expired - Lifetime
- 2001-01-29 JP JP2001555628A patent/JP2003521487A/ja active Pending
- 2001-01-29 AT AT01903990T patent/ATE247956T1/de active
- 2001-01-29 DE DE60100660T patent/DE60100660T2/de not_active Expired - Lifetime
- 2001-01-29 DK DK01903990T patent/DK1251842T3/da active
- 2001-01-29 PT PT01903990T patent/PT1251842E/pt unknown
- 2001-01-29 AU AU2001231931A patent/AU2001231931A1/en not_active Abandoned
- 2001-01-29 WO PCT/FR2001/000271 patent/WO2001054648A2/fr not_active Ceased
- 2001-01-29 TR TR2003/00575T patent/TR200300575T3/xx unknown
- 2001-01-29 EP EP01903990A patent/EP1251842B1/de not_active Expired - Lifetime
-
2012
- 2012-06-14 JP JP2012134680A patent/JP2012197304A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001231931A1 (en) | 2001-08-07 |
| DK1251842T3 (da) | 2003-12-22 |
| DE60100660T2 (de) | 2004-02-26 |
| EP1251842A2 (de) | 2002-10-30 |
| ES2206400T3 (es) | 2004-05-16 |
| US6462089B1 (en) | 2002-10-08 |
| MXPA02007236A (es) | 2003-09-05 |
| TR200300575T3 (tr) | 2003-06-23 |
| JP2003521487A (ja) | 2003-07-15 |
| DE60100660D1 (de) | 2003-10-02 |
| WO2001054648A2 (fr) | 2001-08-02 |
| PT1251842E (pt) | 2004-01-30 |
| WO2001054648A3 (fr) | 2002-06-06 |
| FR2804322B1 (fr) | 2002-04-19 |
| JP2012197304A (ja) | 2012-10-18 |
| EP1251842B1 (de) | 2003-08-27 |
| FR2804322A1 (fr) | 2001-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE327740T1 (de) | Verwendung von acetylcholinesterasen hemmern zur herstellung eines arzneimittels zur behandlung von funktionellen und/oder organischen schmerzsyndromen | |
| DE69428791D1 (de) | Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden | |
| ATE492279T1 (de) | Bupropinmetaboliten zur behandlung von dementia und anderen zerebrovasckulären erkrankungen | |
| ATE206919T1 (de) | Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen | |
| DE60312736D1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| NO20100335L (no) | Behandling av nevrotiske forstyrrelser | |
| DE60318839D1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
| ATE247956T1 (de) | Verwendung von modafinil zur herstellung eines arzneimittels zur behandlung von vigilanzstörungen im zusammenhang mit myopathien | |
| ATE435026T1 (de) | Verfahren zur prävention und behandlung von diabetes mit neurturin | |
| ATE421329T1 (de) | Verwendung von aplidine zur behandlung von kardiovaskulären erkrankungen | |
| DE60128911D1 (de) | Verwendung von l-threo-methylphenidat zur herstellung eines medikamentes zur behandlung von psychischen erkrankungen | |
| DE50010234D1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| ATE361071T1 (de) | Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie | |
| DE60228988D1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
| ATE234613T1 (de) | Verwendung von comt inhibitoren zur herstellung eines arzneimittels zur vorbeugung von diabetischen vaskulären funktionsstörungen | |
| DE60220825D1 (de) | Verwendung von norepinephrinwiederaufnahmehemmern zur behandlung von ticks | |
| DE69701258D1 (de) | Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems | |
| ATE213634T1 (de) | Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts | |
| DE602004023564D1 (de) | Verwendung von Citrullin zur Herstellung eines Arzneimittels zur Behandlung von ans Altern oder an eine Bestrahlung gebundener intestinaler Insuffizienz | |
| ATE245982T1 (de) | Verwendung von 2-amino-6- trifluoromethoxybenzothiazol zur herstellung eines arzneimittels zur vorbeugung oder behandlung von zerebellumkrankheiten | |
| DE50012667D1 (de) | Verwendung von 2-amino-3,4-dihydro-chinazolinen zur herstellung eines medikaments zur behandlung oder prophylaxe von ischämischen zuständen | |
| ATE192650T1 (de) | Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit | |
| ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
| ATE263565T1 (de) | Verwendung von 8,9-dehydroestron zur herstellung eines arzneimittels zur behandlung von durch freie radikale verursachte krankheiten | |
| DE60216090D1 (de) | Verwendung von l-acetylcarnitin zur herstellung eines medikaments zur behandlung von anhedonia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1251842 Country of ref document: EP |